Heart stent study tracks Real-World results in thousands of patients
NCT ID NCT03273023
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 38 times
Summary
This study looked at how well a specific heart stent (PROMUS PREMIER) works in everyday medical practice in China. Over 2,000 patients with coronary artery disease were followed for 12 months to track serious heart events like heart attacks or the need for repeat procedures. The goal was to gather real-world safety and effectiveness data after the stent was already approved for use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Conditions
Explore the condition pages connected to this study.